vs
Side-by-side financial comparison of Innovex International, Inc. (INVX) and LifeStance Health Group, Inc. (LFST). Click either name above to swap in a different company.
LifeStance Health Group, Inc. is the larger business by last-quarter revenue ($382.2M vs $273.6M, roughly 1.4× Innovex International, Inc.). Innovex International, Inc. runs the higher net margin — 5.1% vs 3.1%, a 2.1% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs 9.1%). Over the past eight quarters, Innovex International, Inc.'s revenue compounded faster (46.2% CAGR vs 12.8%).
Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.
INVX vs LFST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $273.6M | $382.2M |
| Net Profit | $14.0M | $11.7M |
| Gross Margin | 28.9% | — |
| Operating Margin | 9.4% | 4.7% |
| Net Margin | 5.1% | 3.1% |
| Revenue YoY | 9.1% | 17.4% |
| Net Profit YoY | -56.1% | 264.1% |
| EPS (diluted) | $0.20 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $273.6M | $382.2M | ||
| Q3 25 | $240.0M | $363.8M | ||
| Q2 25 | $224.2M | $345.3M | ||
| Q1 25 | $240.4M | $333.0M | ||
| Q4 24 | $250.7M | $325.5M | ||
| Q3 24 | $151.8M | $312.7M | ||
| Q2 24 | $130.3M | $312.3M | ||
| Q1 24 | $128.0M | $300.4M |
| Q4 25 | $14.0M | $11.7M | ||
| Q3 25 | $39.2M | $1.1M | ||
| Q2 25 | $15.3M | $-3.8M | ||
| Q1 25 | $14.8M | $709.0K | ||
| Q4 24 | $31.8M | $-7.1M | ||
| Q3 24 | $82.6M | $-6.0M | ||
| Q2 24 | $9.5M | $-23.3M | ||
| Q1 24 | $16.4M | $-21.1M |
| Q4 25 | 28.9% | — | ||
| Q3 25 | 31.6% | — | ||
| Q2 25 | 32.0% | — | ||
| Q1 25 | 31.8% | — | ||
| Q4 24 | 33.9% | — | ||
| Q3 24 | 34.7% | — | ||
| Q2 24 | 35.3% | — | ||
| Q1 24 | 38.4% | — |
| Q4 25 | 9.4% | 4.7% | ||
| Q3 25 | 26.0% | 2.0% | ||
| Q2 25 | 10.1% | -0.9% | ||
| Q1 25 | 9.1% | 0.5% | ||
| Q4 24 | 10.7% | 0.3% | ||
| Q3 24 | -8.7% | 0.0% | ||
| Q2 24 | 10.0% | -5.1% | ||
| Q1 24 | 17.4% | -5.6% |
| Q4 25 | 5.1% | 3.1% | ||
| Q3 25 | 16.3% | 0.3% | ||
| Q2 25 | 6.8% | -1.1% | ||
| Q1 25 | 6.1% | 0.2% | ||
| Q4 24 | 12.7% | -2.2% | ||
| Q3 24 | 54.4% | -1.9% | ||
| Q2 24 | 7.3% | -7.5% | ||
| Q1 24 | 12.8% | -7.0% |
| Q4 25 | $0.20 | — | ||
| Q3 25 | $0.57 | — | ||
| Q2 25 | $0.22 | — | ||
| Q1 25 | $0.21 | — | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $1.99 | — | ||
| Q2 24 | $0.30 | — | ||
| Q1 24 | $0.51 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $248.6M |
| Total DebtLower is stronger | $18.9M | $282.8M |
| Stockholders' EquityBook value | $1.1B | $1.5B |
| Total Assets | $1.3B | $2.2B |
| Debt / EquityLower = less leverage | 0.02× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $248.6M | ||
| Q3 25 | — | $203.9M | ||
| Q2 25 | — | $188.9M | ||
| Q1 25 | — | $134.3M | ||
| Q4 24 | — | $154.6M | ||
| Q3 24 | — | $102.6M | ||
| Q2 24 | $185.6M | $87.0M | ||
| Q1 24 | $202.2M | $49.5M |
| Q4 25 | $18.9M | $282.8M | ||
| Q3 25 | $20.1M | $284.6M | ||
| Q2 25 | $34.8M | $286.4M | ||
| Q1 25 | $19.7M | $288.2M | ||
| Q4 24 | $24.9M | $290.0M | ||
| Q3 24 | $12.4M | $287.3M | ||
| Q2 24 | — | $288.0M | ||
| Q1 24 | — | $288.8M |
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.0B | $1.5B | ||
| Q2 25 | $995.6M | $1.5B | ||
| Q1 25 | $978.4M | $1.5B | ||
| Q4 24 | $958.2M | $1.4B | ||
| Q3 24 | $904.4M | $1.4B | ||
| Q2 24 | $352.5M | $1.4B | ||
| Q1 24 | $344.3M | $1.4B |
| Q4 25 | $1.3B | $2.2B | ||
| Q3 25 | $1.3B | $2.1B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.2B | $2.1B | ||
| Q4 24 | $1.2B | $2.1B | ||
| Q3 24 | $1.1B | $2.1B | ||
| Q2 24 | $1.0B | $2.1B | ||
| Q1 24 | $1.0B | $2.1B |
| Q4 25 | 0.02× | 0.19× | ||
| Q3 25 | 0.02× | 0.19× | ||
| Q2 25 | 0.03× | 0.19× | ||
| Q1 25 | 0.02× | 0.20× | ||
| Q4 24 | 0.03× | 0.20× | ||
| Q3 24 | 0.01× | 0.20× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $52.2M | $57.6M |
| Free Cash FlowOCF − Capex | — | $46.6M |
| FCF MarginFCF / Revenue | — | 12.2% |
| Capex IntensityCapex / Revenue | — | 2.9% |
| Cash ConversionOCF / Net Profit | 3.74× | 4.93× |
| TTM Free Cash FlowTrailing 4 quarters | — | $110.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.2M | $57.6M | ||
| Q3 25 | $48.4M | $27.3M | ||
| Q2 25 | $59.2M | $64.4M | ||
| Q1 25 | $31.1M | $-3.1M | ||
| Q4 24 | $36.3M | $62.3M | ||
| Q3 24 | $21.7M | $22.7M | ||
| Q2 24 | $22.8M | $44.1M | ||
| Q1 24 | $12.6M | $-21.8M |
| Q4 25 | — | $46.6M | ||
| Q3 25 | — | $17.0M | ||
| Q2 25 | — | $56.6M | ||
| Q1 25 | — | $-10.3M | ||
| Q4 24 | — | $56.0M | ||
| Q3 24 | — | $17.7M | ||
| Q2 24 | $16.6M | $39.0M | ||
| Q1 24 | $7.8M | $-26.9M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | -3.1% | ||
| Q4 24 | — | 17.2% | ||
| Q3 24 | — | 5.7% | ||
| Q2 24 | 12.7% | 12.5% | ||
| Q1 24 | 6.1% | -9.0% |
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | 4.7% | 1.6% | ||
| Q1 24 | 3.7% | 1.7% |
| Q4 25 | 3.74× | 4.93× | ||
| Q3 25 | 1.23× | 25.34× | ||
| Q2 25 | 3.86× | — | ||
| Q1 25 | 2.11× | -4.36× | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | 2.39× | — | ||
| Q1 24 | 0.77× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INVX
| Products | $202.7M | 74% |
| Leasing | $42.3M | 15% |
| Services | $28.6M | 10% |
LFST
Segment breakdown not available.
